Long Term Safety and Efficacy Study of SAR442168 in Participants With Relapsing Multiple Sclerosis

Condition:   Relapsing Multiple Sclerosis Intervention:   Drug: SAR442168 Sponsor:   Sanofi Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials